Guardant Health Inc. (GH) Tops Q2 EPS by 23c; Raises Outlook
Guardant Health Inc. (NASDAQ: GH) reported Q2 EPS of ($0.13), $0.23 better than the analyst estimate of ($0.36). Revenue for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)